Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIq-ai Ltd Share News (IQAI)

Share Price Information for Iq-ai Ltd (IQAI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.55
Bid: 1.50
Ask: 1.60
Change: 0.00 (0.00%)
Spread: 0.10 (6.667%)
Open: 1.55
High: 1.55
Low: 1.55
Prev. Close: 1.55
IQAI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK TRADING UPDATE SUMMARY: Airtel And Telkom Abort Kenya Combination

Wed, 05th Aug 2020 22:03

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

Airtel Africa PLC - Africa-focused mobile operator - Subsidiary Airtel Networks Kenya Ltd and Telkom Kenya Ltd business combination in Kenya falls through after "a very lengthy process which has led the parties to reconsider their stance". The two businesses are no longer pursuing completion of the combination.

----------

Adamas Finance Asia Ltd - pan-Asian diversified investment vehicle - Says Future Metal Holdings Ltd asset quarry set to operate at full production for the rest of 2020 after a temporary pause in early 2020 amid the Covid-19 pandemic. Quarry operations in Future Metal's open-pit dolomite quarry in Shanxi Province, China resumed in mid-March. Adamas says that, given the "continuing rapid urbanisation" in China, demand for Future Metal's product is likely to say "robust".

----------

Regency Mines PLC - battery metals company - Proposes name change to Corcel PLC with the aim of more closely reflecting its "strategy to develop its businesses across the battery metals exploration and flexible grid solutions space." Application for name change being made to Companies House and a new website it to be launched.

----------

TP Group PLC - Reading-based software solutions provider - Subsidiary Sapienza Consulting chosen to participate in framework contract providing consulting and technical services for Eurocontrol. Framework to last up to five years and relates to "Common IT Contractor Profiles at the Maastricht Upper Area Control Centre (MUAC) in the Netherlands." Eurocontrol to release restricted tenders to pre-qualified participants for "a range of specialist capabilities" under this framework. Eurocontrol described by TP as "a pan-European civil-military organisation dedicated to supporting European aviation".

----------

MediaZest PLC - London-based audio visual services provider - Raises GBP150,000 through issue of unsecured convertible loan notes with maturity date August 2023. Proceeds will provide more working capital for MediaZest and have interest of 7% per annum. Chief Executive Geoff Robertson: "We are delighted to announce the fundraise at a difficult time for all businesses and we're grateful for the continuing support of shareholders as we move out of the UK lockdown period and seek to build on the group's encouraging performance in the run up to the Covid-19 outbreak."

----------

Hummingbird Resources PLC - African gold producer - Provides second quarter operational and trading update on Yanfolila showing 24,054 ounces gold poured in period, down from 27,466 ounces in the same quarter of 2019. Sells 31,520 ounces of gold at USD1,663 average price per ounce. All in sustaining cost for Yanfolila USD963 per ounce versus USD998 year-on-year. Recordable injury frequency rate 2.3, under 2.5 target. June 30 cash USD6 million versus USD9 million December 31 and 4,000 ounces gold inventory on hand compared to 2.900 ounced 2019 end worth around USD8 million. Reduces bank debt by USD14 million from December to USD26 million. Maintains 2020 guidance for 11,000 to 125,000 ounces and ASIC USD995 per ounce. On track for net cash position target in second half with bank loans repaid by end of 2021 first half. Q2 Yanfolila mine drill intersections received includes 5.7 metres at 16.42 grams per tonne of ore from 263 metres depth.

----------

IQ-AI Ltd - medical software company with headquarters in Jersey - Signs letter of intent with undisclosed "major international medical group" that wishes to buy StoneChecker Software Ltd. The sale is part of IQ-AI's decision to focus on neuro imaging. StoneChecker analyses CT assets the evaluate the likelihood of a kidney stone breaking up when a patient undergoes lithotripsy, where shock waves are used to break up kidney stones. This procedure fails 29% of the time and StoneChecker would therefore reduce the the number of these failed procedures. If completed, the sales will involve a cash consideration as well as ongoing royalty on sales.

----------

Cora Gold Ltd - West African focused gold company - Says warrant holders have exercised their right to subscribe for 55,564 depositary interests at 10 pence each, raising GBP55,556 in total.

----------

NB Global Floating Rate Income Fund Ltd - closed-ended investment company incorporated in Guernsey - Intends to propose investment policy amendment and institure new discount control mechanism. This includes a revised investment objective letting it invest in a broader range of assets such as alternative credit. It will also pay income on a monthly basis starting from the declaration of its third quarter dividend. It explains: "The new investment objective will mean the trust can still invest in 'senior secured, floating rate' loans where the majority of its portfolio is currently held, but will also be able to invest in a broad range of other debt types." New proposals will involve a tender offer to let shareholder exist the trust, which is trading on an 8% discount, at a 2% discount. The discount control policy will let investors tender shares at a 3% discount every six months.

----------

Tiziana Life Sciences PLC - London-headquartered biotechnology company focused on innovative therapeutics for oncology, inflammation and infectious diseases - Closes American Depositary Shares registered direct offering. Issues 11.0 million ADSs as USD5.20 each raising USD57.25 million gross. ThinkEquity, division of Fordham Financial Management Inc, is sole placement agenct. Proceeds will help advance clinical development of Foralumab and allow it to start a trial in HCC patients with Milciclib. Funds also assist in expediating clinical development of TZLS-501 for Covid-19.

----------

Columbus Energy Resources PLC - oil and gas producer and explorer focused on onshore Trinidad and Suriname - Gets court sanction for scheme to effect merger with Bahamas Petroleum Co PLC, expected to be effective August 7. August 6 to be last day of dealings in Columbus shares.

----------

By Anna Farley; annafarley@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
22 Feb 2024 14:02

IN BRIEF: IQ-AI shares sink on discounted placing fundraise

IQ-AI Ltd - Medical services firm and parent company of Wisconsin-based healthcare imaging software firm Imaging Biometrics LLC - Announces placing to raise GBP300,000 gross proceeds via the issue of 20.0 million new shares at a price of 1.5p each. The issue price represents a discount of 32% to the company's Wednesday closing price of 2.2p. The placing includes a broker option for existing shareholders for up to 6.7 million new shares, which would raise an additional GBP100,000. Admission of the new placing and broker option shares is expected to occur on or around March 1.

Read more
9 Feb 2024 13:38

IQ-AI subsidiary asked by FDA to resubmit and modify application

(Alliance News) - IQ-AI Ltd on Friday said its subsidiary Imaging Biometric LLC will modify and resubmit its application to the US Food & Drug Administration.

Read more
2 Feb 2024 08:56

IN BRIEF: IQ-AI celebrates USD100,000 grant for subsidiary

IQ-AI Ltd - St Helier, Jersey-based medical services firm - Says that Imaging Biometrics LLC, a wholly-owned subsidiary of IQ-AI, has been given a USD100,000 grant by the Musella Foundation For Brain Tumor Research & Information Inc. Explains that the grant will help to support the launch of an intermediate group expanded access programme, which is focused on giving brain tumour patients access to oral gallium maltolate, outside of an ongoing Phase One clinical trial at the Medical College of Wisconsin. The grant will be used to facilitate the expanded access programme, including writing and submitting the study protocol, patient screening and on-boarding.

Read more
10 Jan 2024 11:48

IQ-AI falls after subsidiary notes launch of treatment access scheme

(Alliance News) - IQ-AI Ltd shares fell on Wednesday, after it said its subsidiary Imaging Biometrics LLC is launching an intermediate population cohort expanded access programme for oral gallium maltolate.

Read more
19 Dec 2023 17:00

IQ-AI firm gets US FDA fast-track status for oral gallium maltolate

(Alliance News) - IQ-AI Ltd on Tuesday said the US Food & Drug Administration has granted 'fast-track" designation for oral gallium maltolate, which is its subsidiary Imaging Biometrics LLC's therapeutic for the treatment of adult patients with relapsed or refractory glioblastoma.

Read more
5 Dec 2023 11:49

IQ-AI stock rises on positive interim results from glioblastoma trial

(Alliance News) - IQ-AI Ltd on Tuesday reported positive results from Phase 1 of an on-going study for its investigational monotherapy oral gallium maltolate.

Read more
8 Nov 2023 12:04

IQ-AI says Imaging Biometrics submits paediatric rare disease request

(Alliance News) - IQ-AI Ltd on Wednesday said its wholly-owned subsidiary Imaging Biometrics LLC has submitted a paediatric rare disease request to the US Food & Drug Administration for its gallium maltolate therapy.

Read more
18 Oct 2023 17:11

IN BRIEF: IQ-AI subsidiary "central" to "landmark" brain cancer study

IQ-AI Ltd - St Helier, Jersey-based medical services firm focused on cancer treatment - Notes its wholly-owned subsidiary, Imaging Biometrics LLC (IB), has announced the results of a "landmark" study. Says the study represents the first large-scale characterization of the invasive tumour margins of high-grade glioma using multi-regional genomic/transcriptomic sequencing with spatially matched MRI measurements in glioma. High-grade glioma is a deadly brain cancer. Explains that Imaging Biometrics' IB Neuro's dynamic susceptibility contrast magnetic resonance imaging software was central to the study.

Read more
9 Oct 2023 12:09

IN BRIEF: IQ-AI subsidiary wins orphan drug designation from US FDA

IQ-AI Ltd - St Helier, Jersey-based medical services firm focused on cancer treatment - Wholly-owned subsidiary Imaging Biometrics LLC is granted an orphan drug designation from the US Food & Drug Administration for gallium maltolate for the treatment of atypical teratoid rhabdoid tumour. Notes this is the second orphan designation granted to gallium maltolate this year.

Read more
8 Sep 2023 10:25

IQ-AI notes vindication of subsidiary's reduced gadolinium approach

(Alliance News) - IQ-AI Ltd on Friday noted that studies by its subsidiary Imaging Biometrics LLC validated the dosing approach of Imaging's MRI-focused IB Neuro.

Read more
18 Aug 2023 12:17

IQ-AI shares jump on subsidiary's GE Healthcare deal

(Alliance News) - IQ-AI Ltd on Friday said its wholly-owned subsidiary Imaging Biometrics LLC has signed a deal with GE HealthCare Technologies Inc.

Read more
17 Aug 2023 11:21

IQ-AI interim loss narrows amid higher revenue, lower expenses

(Alliance News) - IQ-AI Ltd on Thursday announced a slightly lower loss for the six months to June 30, as revenue was up and administrative expenses were lower.

Read more
19 Jul 2023 10:45

IN BRIEF: IQ-AI subsidiary's app adopted by US medical college

IQ-AI Ltd - Jersey-based medical services firm focused on cancer treatment - Says subsidiary Imaging Biometrics LLC's handheld application IB Nimble has been adopted by the Medical College of Wisconsin's Orthopedic Department for use in bone metastases treatment. IB Nimble's designer, Joseph Bovi, is professor of radiation oncology & neurosurgery at MCW. The application was originally designed to help treat brain metastases. IQ-AI says it "provides real-time collaboration amongst multi-disciplinary teams" to "provide optimised treatments faster". Josh McComack, Imaging Biometrics' director of software engineering, says the new installation "demonstrates that IB Nimble is ready for widespread deployment."

Read more
13 Jul 2023 11:36

IN BRIEF: IQ-AI granted orphan drug designation for Gallium Galtolate

IQ-AI Ltd on Thursday - Jersey-based incubator of software and other tools for the treatment of cancer - IQ-AI subsidiary Imaging Biometrics LLC has been granted an orphan drug designation for Gallium Galtolate for the treatment of paediatric glioblastoma multiforme, or GBM, by the US Food & Drug Administration. Says GBM is the most common and aggressive primary brain tumour in adults and children. Imaging Biometrics' application to the FDA was first submitted in April. In June, two pre-clinical studies showed oral GaM inhibits brain tumour growth in children, and the results were consistent with previous work conducted in the Schmainda Lab at the Medical College of Wisconsin.

Read more
27 Jun 2023 11:47

IN BRIEF: IQ-AI notes Gallium Moltate studies on tumour growth

IQ-AI Ltd - Jersey-based medical services firm - Says subsidiary Imaging Biometrics LLC's two new pre-clinical studies show oral Gallium Maltolate inhibits brain tumour growth in children. Says the results are consistent with previous work conducted in the Schmainda Lab at the Medical College of Wisconsin. This follows IB's application for Orphan Drug Designation to the US Food & Drug Administration back in April for the use of GaM in pediatric brain tumours. Notes application is currently under review.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.